Listen: Legal insider trading, booming biotech stocks, & the next GLP-1
This week on "The Readout LOUD": Are biotech's dog days over? What's a PIPE? And what can unseat Wegovy?
Are biotech’s dog days over? What’s a PIPE? And what can unseat Wegovy?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We dive into the the latest craze in the world of biotech finance, involving hedge funds and some insider information, and explain why not everyone thinks it’s such a good idea. We also discuss a banner month for biotech stocks and the latest twist in obesity research.
What's Your Reaction?
